Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Long term survival in metastatic colorectal cancer treated with leucovorin and 5-fluoro-uracil chemotherapy].
La Revue de medecine interne·2004
Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer.
European journal of cancer (Oxford, England : 1990)·2002
[Meningeal carcinomatosis in gastric cancer].
Gastroenterologie clinique et biologique·2001
High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7).
European journal of cancer (Oxford, England : 1990)·2001
Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR).
Annals of oncology : official journal of the European Society for Medical Oncology·2001
Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.
Presse medicale (Paris, France : 1983)·2026
Artificial intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.
Presse medicale (Paris, France : 1983)·2026
AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.
Presse medicale (Paris, France : 1983)·2026
Artificial Intelligence in medical research and publishing: Progress, risks, and future perspectives.
Presse medicale (Paris, France : 1983)·2026
Ethical, legal, and regulatory challenges in AI-based healthcare tools.
Presse medicale (Paris, France : 1983)·2026
Beyond one-size-fits-all: Personalising health communication to drive real behaviour change.
Presse medicale (Paris, France : 1983)·2026